Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis von Balk, L J, Steenwijk, M D, Tewarie, P, Daams, M, Killestein, J, Wattjes, M P, Vrenken, H, Barkhof, F, Polman, C H, Uitdehaag, B M J, Petzold, A

Volltext

Predicting clinical progression in multiple sclerosis after 6 and 12 years von Dekker, I., Eijlers, A. J. C., Popescu, V., Balk, L. J., Vrenken, H., Wattjes, M. P., Uitdehaag, B. M. J., Killestein, J., Geurts, J. J. G., Barkhof, F., Schoonheim, M. M.

Volltext

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study von Leurs, CE, Twaalfhoven, HAM, Lissenberg-Witte, BI, van Pesch, V, Dujmovic, I, Drulovic, J, Castellazzi, M, Bellini, T, Pugliatti, M, Kuhle, J, Villar, LM, Alvarez-Cermeño, JC, Alvarez-Lafuente, R, Hegen, H, Deisenhammer, F, Walchhofer, LM, Thouvenot, E, Comabella, M, Montalban, X, Vécsei, L, Rajda, C, Galimberti, D, Scarpini, E, Altintas, A, Rejdak, K, Frederiksen, JL, Pihl-Jensen, G, Jensen, PEH, Khalil, M, Voortman, MM, Fazekas, F, Saiz, A, La Puma, D, Vercammen, M, Vanopdenbosch, L, Uitdehaag, BMJ, Killestein, J, Bridel, C, Teunissen, C

Volltext

Early-warning signals for disease activity in patients diagnosed with multiple sclerosis based on keystroke dynamics von Twose, J., Licitra, G., McConchie, H., Lam, K. H., Killestein, J.

Volltext

Information processing speed in multiple sclerosis: Relevance of default mode network dynamics von van Geest, Q., Douw, L., van 't Klooster, S., Leurs, C.E., Genova, H.M., Wylie, G.R., Steenwijk, M.D., Killestein, J., Geurts, J.J.G., Hulst, H.E.

Volltext

Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis von Lam, KH, Meijer, KA, Loonstra, FC, Coerver, EME, Twose, J, Redeman, E, Moraal, B, Barkhof, F, de Groot, V, Uitdehaag, BMJ, Killestein, J

Volltext

Reliability, construct and concurrent validity of a smartphone-based cognition test in multiple sclerosis von Lam, KH, van Oirschot, P, den Teuling, B, Hulst, HE, de Jong, BA, Uitdehaag, BMJ, de Groot, V, Killestein, J

Volltext

Multimodal MRI study on the relation between WM integrity and connected GM atrophy and its effect on disability in early multiple sclerosis von Weeda, Merlin M., van Nederpelt, D. R., Twisk, J. W. R., Brouwer, I., Kuijer, J. P. A., van Dam, M., Hulst, H. E., Killestein, J., Barkhof, F., Vrenken, H., Pouwels, P. J. W.

Volltext

Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women von Kragt, JJ, van Amerongen, BM, Killestein, J, Dijkstra, CD, Uitdehaag, BMJ, Polman, CH, Lips, P

Volltext

Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial von Toorop, A.A., Wessels, M.H.J., Gelissen, L.M.Y., Hoitsma, E., Zeinstra, E.M.P.E., van Rooij, L.C., van Munster, C.E.P., Vennegoor, A., Mostert, J.P., Wokke, B.H.A., Kalkers, N.F., Hoogervorst, E.L.J., van Eijk, J.J.J., Roosendaal, C.M., Kragt, J.J., Eurelings, M., van Genugten, J., Nielsen, J., Sinnige, L.G.F., Kloosterziel, M.E., Arnoldus, E.P.J., van Dijk, G.W., Bouvy, W.H., Strijbis, E.M.M., van Oosten, B.W., de Jong, B.A., Lissenberg-Witte, B.I., Rispens, T., Uitdehaag, B.M.J., Killestein, J., van Kempen, Z.L.E.

Volltext

High cumulative JC virus seroconversion rate during long-term use of natalizumab von Vennegoor, A., van Rossum, J. A., Leurs, C., Wattjes, M. P., Rispens, T., Murk, J. L. A. N., Uitdehaag, B. M. J., Killestein, J.

Volltext

Predictors of unfavourable outcome in adults with suspected central nervous system infections: a prospective cohort study von ter Horst, Liora, van Zeggeren, Ingeborg E., Olie, Sabine E., van de Beek, Diederik, Brouwer, Matthijs C.

Volltext

Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis von van de Kraats, C, Killestein, J, Popescu, V, Rijkers, E, Vrenken, H, Lütjohann, D, Barkhof, F, Polman, CH, Teunissen, CE

Volltext

Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanne... von Weeda, M.M., Middelkoop, S.M., Steenwijk, M.D., Daams, M., Amiri, H., Brouwer, I., Killestein, J., Uitdehaag, B.M.J., Dekker, I., Lukas, C., Bellenberg, B., Barkhof, F., Pouwels, P.J.W., Vrenken, H.

Volltext

Variations in consecutive serum neurofilament light levels in healthy controls and multiple sclerosis patients von Bridel, C., Verberk, I.M.W., Heijst, J.J.A., Killestein, J., Teunissen, C.E.

Volltext

Disease course heterogeneity and OCT in multiple sclerosis von Balk, LJ, Tewarie, P, Killestein, J, Polman, CH, Uitdehaag, BMJ, Petzold, A

Volltext

Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis von Coerver, E.M.E., Bourass, A., Wessels, M.H.J., van Kempen, Z.L.E., Jasperse, M.M.S., Tonino, B.A.R., Barkhof, F., Mostert, J., Uitdehaag, B.M.J., Killestein, J., Strijbis, E.M.M.

Volltext

Seizures in adults with suspected central nervous system infection von Olie, Sabine E, van Zeggeren, Ingeborg E, ter Horst, Liora, Citroen, J, van Geel, B. M, Heckenberg, S. G. B, Jellema, K, Kester, M. I, Killestein, J, Mook, B. B, Titulaer, M. J, van Veen, K. E. B, Verschuur, C. V. M

Volltext

Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data von Noteboom, S., Strijbis, E.M.M., Coerver, E.M.E., Colato, E., van Kempen, Z.L.E., Jasperse, B., Vrenken, H., Killestein, J., Schoonheim, M.M., Steenwijk, M.D.

Volltext

The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis von Toorop, A.A., van Lierop, Z.Y.G.J., Strijbis, E.M.M., Teunissen, C.E., Barkhof, F., Uitdehaag, B.M.J., van Kempen, Z.L.E., Killestein, J.

Volltext